Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome

Source:
By:yunchao huang

DOI: https://doi.org/10.30564/jams.v3i1.1451

Abstract:

Objective: To study the M receptor blocker on inhalation in patients with overlap syndrome (chronic obstructive pulmonary disease and Obstructive sleep apnea syndrome) curative effect analysis. Methods: 25 patients with overlap syndrome as the experimental group, chronic obstructive pulmonary disease patients (30) as control group, patients with overlap syndrome use inhaled tiotropium powder treat 30 days, to observe the changes of pulmonary function, polysomnography, and other indicators after treatment. Results: Overlap syndrome were treated by tiotropium bromide inhalation powder, has improved the pulmonary function, the sleep apnea index and lowest nocturnal oxygen saturation after treatment. Conclusion: tiotropium bromide has a preferable effective in treatment of overlap syndrome, COPD and OSAHS are interacting with each other.

References:

[1] Weitzenblum E, Chaouat A, Kessler R, et al. The Overlap Syndrome: association of COPD and Obstructive Sleep Apnoea. Rev Mal Respir. 2010 Apr; 27(4):329-40. [2] Pronzato C. Chronic obstructive pulmonary disease and obstructive sleep apnea. Association, constraints and treatment. Am J Respir Crit Care Med. 2009 Oct 15; 180(8):692-700. [3] Kim KS, Kim JH, Park SY, et al.Smoking induces oropharyngeal narrowing and increases the severity of obstructive sleep apnea syndrome. J Clin Sleep Med. 2012 Aug 15; 8(4):367-74. [4] Xianmei Liang. Obstructive sleep apnea syndrome and pulmonary function. Chinese Medical Abstracts, Internal Medicine, 2006, 27(1):24-5. (in Chinese) [5] Coiiop N. Sleep and sleep disorders in chronic obstructive pulmonary disease. Respiration, 2010, 80(1):78-86. [6] Drager LF, Bortol otto LA, Loren zi MC, et al. Early signs of atheroscleros is in obstructive sleep apnea[J] . Am J Respir Crit Care Med, 2005, 172(5):613-8. [7] Yohannes AM, Connolly MJ, Hanania NA.Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25. [8] Qian Jianmei, Guifang Wang. Research progress of long-acting anticholinergic drug tiotropium. International Journal of Respiratory, 2010, 30(23):1467-9. (in Chinese) [9] Yunchao Huang, Xiao Li, Ao Liu. Advances in the pathogenesis of obstructive sleep apnea hypopnea syndrome. Journal of Clinical Pulmonary Medicine, 2013, 5(18):898-9. (in Chinese) [10] Liang Ye, Qingyun Li, Min Li. Advances in research on chronic intermittent hypoxia and sympathetic abnormal excitability. Chinese Journal of Respiratory and Critical Care, 2009, 8(6):609-11. (in Chinese) [11] Curry DT, Eisenstein RD, Walsh JK. Pharmacologic management of insomnia: past, present, and future[J]. Psychiatr Clin N Am, 2006, 29(4):871-93. [12] Tatiana D Carvalho, Carlos Marcelo Pastre, et al. Fractal correlation property of heart rate variability in chronic obstructive pulmonary disease. International Journal of COPD 2011; 6:23-28. [13] Nural S, Gunay E, Halici B, et al. Inflammatory processes and effect of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammationg, 2013136(1):66-74.